Cocos nucifera L. inflorescence extract: An effective hepatoprotective agent by George, Varughese et al.
Indian Journal of Traditional Knowledge 







Cocos nucifera L. inflorescence extract: An effective hepatoprotective agent 
Manikantan Ambika Chithra1,2, Thadiyan Parambil Ijinu1, Harsha Kharkwal2, Rajeev Kumar Sharma3,  
Kainoor Krishnankutty Janardhanan4, Palpu Pushpangadan1 & Varughese George*,1,+ 
1Amity Institute of Phytochemistry and Phytomedicine, Peroorkada PO, Thiruvananthapuram 695 005, Kerala, India 
2Amity University Uttar Pradesh, Noida 201 303, Uttar Pradesh, India 
3Pharmacopoeial Laboratory for Indian Medicine, Department of AYUSH, Ghaziabad, Uttar Pradesh 201 002, India 
4Amala Cancer Research Centre, Amala Nagar, Thrissur 680 555, Kerala, India 
E-mail: chithramankoikkal@gmail.com; ijinutp@gmail.com; hkharkwal@amity.edu; rajeevsharma.herb@gmail.com; 
kkjanardhanan@yahoo.com; palpuprakulam@yahoo.co.in; +georgedrv@yahoo.co.in 
Received 15 February 2019; revised 30 July 2019 
The flowering inflorescence of Cocos nucifera, a main constituent of several traditional drug formulations was 
investigated with a view to study the effect of the acetone extract of C. nucifera inflorescence (CnAE) on acetaminophen-
induced hepatotoxicity. The total phenol and flavonoid contents of the extract are found to be 222.6 µg gallic acid 
equivalent/g and 120.8 µg quercetin equivalent/g, respectively. The LD50 value was >5000 mg/kg b.w. The antioxidant 
activity was assessed using three methods, namely, 2,2’- diphenyl-1-picryl hydrazyl assay, 2,2’-azinobis  
(3-ethylbenzthiazoline-6-sulphonic acid) assay and ferric reducing antioxidant power assay and the IC50 values were found 
to be 65.72, 66.94 and 89.84 μg/mL, respectively. Effect of CnAE (100, 200 and 400 mg/kg b.w.) and silymarin (100 mg/kg 
b.w.) against acetaminophen-induced liver toxicity was evaluated in Wistar rats. The study showed that CnAE pre-treated 
groups remarkably prevented the increase in serum alanine amino transferase, aspartate amino transferase and alkaline 
phosphatase level and decrease in the level of liver superoxide dismutase, reduced glutathione, glutathione-S-transferase and 
glutathione peroxidise. The extract also suppressed the elevated level of malondialdehyde. The biochemical determinations 
supported the histopathological examination and blood parameter findings. The findings of our study indicated that the 
phenolic-rich CnAE could be an interesting alternative candidate against acetaminophen-induced hepato-toxicity and 
associated oxidative stress. 
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Cocos nucifera L. (fam. Arecaceae, Coconut tree), a 
monocotyledonous plant has been known as 
Kalpavriksha/Kalpataru/Kalpadruma in Sanskrit 
meaning wish-fulfilling divine tree in Indian mythology. 
C. nucifera is considered as the nature’s greatest gift 
to man since every part of the tree is useful in one-
way or other to mankind. The plant is native to 
Southeast Asia1. In Ayurveda, the inflorescence is 
used for the treatment of menorrhagia and back 
pain2,3. The fresh kernel is an ingredient of many 
Indian food preparations like puddings, sweets, 
curries, chutneys etc. C. nucifera has been the subject 
of investigation in several laboratories and a number 
of papers are available in the literature4-10.  
Liver diseases are one of the fatal diseases and 
over 10% of the world population are afflicted by 
liver diseases11,12. Available drugs are often limited 
in efficacy with serious adverse effects eventually 
causing hepatic damage and are generally expensive. 
About 50% of the cases of acute liver failure are 
caused by drug toxicity and is responsible for all 
forms of acute and chronic liver diseases13. 
Literature search shows that many of the 
hepatoprotective drugs in the market and under 
clinical investigations are of natural origin14. 
Therefore, we thought it desirable to study the effect 
of C. nucifera inflorescence against acetaminophen-
induced liver toxicity. 
 
Materials and methods 
 
Drugs and chemicals 
Chemicals, reagents and drug standards were 
obtained from Sigma-Aldrich, USA. The analytical 
kits for serum and blood parameters were purchased 
from Agappe Diagnostics Ltd., India.  ———— *Corresponding author 




Collection of plant material and preparation of extract 
The Cocos nucifera (Cn) inflorescence was 
obtained from southern Western Ghats region of 
Thiruvananthapuram district, Kerala, India. The fresh 
inflorescence (950 g) was extracted with 4 x 3000 mL 
acetone for 48 h and the extracts were filtered and 
pooled. The pooled extracts were concentrated by 
evaporation. The extract thus obtained (CnAE) was 
kept at 4°C until used. 
 
Experimental animals  
Wistar rats (male, 180-230 g) and Swiss albino 
mice (either sex, 25-30 g) were used in this study. 
Experiments were done according to OECD 
guidelines, after getting the approval of the Institute’s 
Animal Ethics Committee (IAEC), Amala Cancer 
Research Centre, India (Reg. No.149/199/CPCSEA). 
 
Qualitative analysis of phytoconstituents  
Standard protocols were used for the preliminary 
phytochemical analysis of CnAE15,16. 
 
Quantitative analysis of phytoconstituents 
 
Estimation of total phenolic content 
Folin-Ciocalteu method was used to find out the 
total phenolic content (TPC) of CnAE17. Each 
analysis was carried out in triplicate, values are 
expressed in mean ± SD and results are given in µg 
GAE (gallic acid equivalents)/g dry extract. 
 
Estimation of total flavonoid content 
Aluminum chloride colorimetric method was used 
to determine the total flavonoid content (TFC) of 
CnAE18. Each analysis was done in triplicate, values 
are expressed in mean ± SD and results are given in 
µg QE (quercetin equivalents)/g dry extract. 
 
Acute toxicity study  
The experiment was done in accordance with 
OECD guideline 423 (OECD, 2001). Mice were 
divided into 7 groups of 6 animals each. Prior to 
dosing with CnAE, mice were fasted overnight, but 
were allowed free access to water. Group I, normal 
(negative control) received distilled water and Groups 
II-VII were treated with 500, 1000, 2000, 3000, 4000 
and 5000 mg/kg b.w. of CnAE (po). All the animals 
were observed continuously for first 3 h, then 1 h 
intermittently up to 24 h for behavioural changes. 
Post-treatment observation for toxic symptoms was 
continued, twice daily for 14 days. 
 
Antioxidant activity assay 
DPPH radical scavenging assay 
The DPPH radical scavenging activity of CnAE 
was determined according to the method described by 
Aquino et al.19. Ascorbic acid was used as standard. 
The percentage of free radical scavenging activity of 
the sample was calculated according to the formula: 
 
% of DPPH radical scavenging = [(A0 – A1) / A0] x 
100 
 
Where, A0 = absorbance of the control and A1 = 
absorbance of sample 
 
ABTS radical scavenging assay 
The ABTS radical scavenging activity of CnAE 
was performed by the previously described method20.  
 
FRAP assay 
The FRAP assay was performed according to the 
method described by Benzie and Strain21.  
 
Acetaminophen-induced hepatotoxicity study 
The hepatoprotective activity of CnAE was 
investigated according to the method described by 
Ajith et al.22 with some modifications (Fig. 1). All the 
animals were euthanized after four hours of APAP 
treatment, blood and liver samples were collected for 
biochemical, haematological and histological studies. 
 
Evaluation of serum enzyme status 
The serum levels of aspartate aminotransferase 
(AST, EC 2.6.1.1) and alanine aminotransferase 
(ALT, EC 2.6.1.2) were measured by the method 
described by Reitman and Frankel23, Alkaline 
phosphatase (ALP, EC 3.1.3.1) was measured by 
Kind and King method24 using assay kits. 
 
Evaluation of liver tissue antioxidant status 
Liver samples collected were washed with ice-cold 
saline (0.89 %) and 10 % homogenate was prepared 
in PBS (0.05 M, pH 7) using a polytron homogenizer 
at 4 oC. The homogenate was centrifuged at 3000 rpm 
for 20 min to remove the cell debris. The supernatant 
obtained was used for the estimation of liver tissue 
antioxidant parameters such as superoxide dismutase 
(SOD, EC 1.15.1.1)25, reduced glutathione (GSH)26, 
glutathione peroxidase (GPx, EC 1.11.1.9)27, 
glutathione S-transferase (GST, EC 2.5.1.18)28 and 




Fig. 1 — Experimental design and the interval for estimation of 
various parameters 




Haematological study  
Blood samples collected in EDTA coated vials 
were used to perform haematology analysis using an 
auto-haematology analyser (Mindray BC-2800Vet, 




Liver samples were fixed in 10% formalin and 
embedded in paraffin. Sections (5 μm) were prepared 
from each liver sample using rotary microtome and 
are stained with hematoxilin-eosin (H&E). All the 
slides stained were examined for pathological 
findings of liver toxicity using a microscope 
(Labomed LX 400, USA). 
 
Liquid chromatography-high resolution mass spectrometry 
analysis  
Liquid chromatography-high resolution mass 
spectrometry (LC-MS, 1290 Infinity UHPLC System, 
1260 infinity Nano HPLC with Chipcube, 6550 
iFunnel Q-TOFs) analysis was carried out for the 
identification of chemical constituents in CnAE30. The 
mass spectra obtained were processed using Agilent 
MassHunter Q-TOF B.05.01 (B5125.1) software. 
 
Statistical analysis 
All data were represented as mean ± SD. Linear 
regression analysis was carried out for standards to 
calculate total phenolic and flavonoid contents, and 
the IC50 value was analysed using non-linear 
regression using Microsoft Excel 2007 (Microsoft 
Corporation, USA). In animal studies, significant 
difference between the mean values were statistically 
analyzed using one-way analysis of variance 
(ANOVA) followed by Dunnett’s t test using In Stat 3 
software (GraphPad Software, Inc., USA). p<0.05 




Evaluation of phytoconstituents  
Preliminary phytochemical screening of CnAE 
showed the presence of phenolics, coumarins, 
steroids, terpenoids, saponins and carbohydrates. The 
total phenolic and flavonoid content were found to be 
222.61 µg GAE/g dry extract and 120.83 µg QE/g dry 
extract, respectively. 
 
Acute toxicity study 
No mortality was recorded after 14 days of 
treatment (Table 1). Therefore the LD50 value is 
>5000 mg/kg b.w. All the animals in the treated group 
did not show any significant decrease in body weight, 
food and water consumption for all the 14 days, when 
compared with the zero day values. Also there is no 
behavioural change after the drug administration. The 
cage side observations of animals are presented in 
Table 2. 
 
DPPH radical scavenging assay 
It was observed that CnAE dose-dependently 
increased the DPPH radical scavenging activity  
(Fig. 2). Higher concentration of CnAE (100 μg/mL) 
showed 72.50% of DPPH radical scavenging activity. 
The IC50 value of CnAE was found to be 65.72 μg/mL 
and of reference standard ascorbic acid was 7.63 μg/mL. 
 
ABTS radical scavenging assay 
The result showed that CnAE demonstrated a dose-
dependent ABTS radical scavenging activity (Fig. 3). 
Table 1 — Mortality latency and toxic symptoms of animals 
administered with different concentrations of CnAE in acute 
toxicity study 
Treatment Dose  
(mg/kg b.w.) 




Control - M 0/3 - None 
F 0/3 - None 
CnAE 500 M 0/3 - None 
F 0/3 - None 
CnAE 1000 M 0/3 - None 
F 0/3 - None 
CnAE 2000 M 0/3 - None 
F 0/3 - None 
CnAE 3000 M 0/3 - None 
F 0/3 - None 
CnAE 4000 M 0/3 - None 
F 0/3 - None 
CnAE 5000 M 0/3 - None 
F 0/3 - None 
D/T = Dead/Treated mice  
 
Table 2 — Cage side observations of animals administered with 
different concentrations of CnAE in acute toxicity study 
Parameters observed Cage side observations 
(500 – 5000 mg/kg b.w) 
Condition of the fur Normal 
Skin Normal 
Subcutaneous swellings Nil 
Abdominal distension Nil 
Eyes – dullness Nil 
Eyes – opacities Nil 
Pupil diameter Normal 
Ptosis Nil 
Colour and consistency of the faeces Normal 
Wetness or soiling of the perineum Nil 
Condition of teeth Normal 
Breathing abnormalities Nil 
Gait Normal 




At the higher concentration (100 μg/mL), CnAE 
scavenged 69.96% of ABTS radicals. The IC50 value 
of CnAE was found to be 66.94 μg/mL and of 
reference standard ascorbic acid was 9.32 µg/mL. 
 
FRAP assay 
CnAE showed ferric ion reducing activity in  
a dose-dependent manner (Fig. 4). At 100 µg/mL 
concentration, CnAE showed 53.75% of ferric 
reducing antioxidant power. The IC50 value of CnAE 
is found to be 89.84 μg/mL and of reference standard 
ascorbic acid was found to be 11.06 µg/mL. 
 
Acetaminophen-induced hepatotoxicity  
Oral administration of acetaminophen (3 g/kg bw) 
caused significant hepatic damage as evidenced by  
the altered serum biochemical parameters, liver 
antioxidant status, haematological parameters and 
histopathology.  
 
Serum enzyme activity 
Acetaminophen administration significantly 
augmented the serum AST, ALT and ALP levels 
(p<0.001), when compared with the normal control 
group (Table 3). However, pre-treatment with CnAE 
at doses of 100, 200 and 400 mg/kg b.w. decreased 
the serum AST, ALT and ALP levels to varying 
extents in the APAP-treated rats. CnAE (400 mg/kg 
b.w.) significantly suppressed the elevated levels of 
AST, ALT and ALP in serum (p<0.05).  
 
Liver antioxidant status 
The study demonstrated that APAP administration 
to the rats affected the liver antioxidant status, as 
evidenced by changes in SOD, GSH, GPx and GST 
activities and MDA level, when compared to the 
normal control group (Table 4). The APAP-induced 
decrement in SOD, GSH, GPx and GST activities was 
dose-dependently attenuated in CnAE pre-treated 
groups. The middle and high doses of CnAE (200 and 
400 mg/kg b.w.) significantly augmented the SOD, 
GSH, GPx and GST activities (p<0.001). The GST 
activity of high dose of CnAE (400 mg/kg bw)  
treated group is comparable with the silymarin  
treated group.  
APAP-administration drastically increased the liver 
MDA level (p<0.001) and pre-treatment with CnAE 
suppressed the level of MDA in a dose-dependent 
manner. At higher dose of 400 mg/kg bw the level of 
MDA significantly decreased (p<0.01). Treatment 
with drug standard, silymarin also manifested a 




Acetaminophen-induced hepatic toxicity caused an 
increase in RBC and WBC counts and a decrease  
in platelet count (Table 5). Oral administration of 
different concentrations (100, 200 and 400 mg/kg 
b.w.) of CnAE every day for fifteen days prior to the 
APAP-treatment resulted in attenuated levels of all 
the haematological parameters tested, in a dose 
dependent manner. CnAE at a dose of 400 mg/kg bw 
significantly (p<0.001) augmented the platelet  
count and declined the RBC and WBC counts 
 
 










Fig. 4 — Ferric reducing antioxidant power of CnAE at different 
concentrations 
 




(p<0.001). The restorative effect of high dose of 




Liver sections of normal control group showed 
normal cellular architecture and the toxin control 
showed fatty infiltration and necrosis together with 
massive neutrophilic and lymphocytic infiltration. 
However, in CnAE pre-treated groups these changes 
were reduced to moderate to low (Fig. 5). 
 
LC-MS analysis 
Liquid chromatography-mass spectrometry analysis 
of CnAE showed the presence of 92 compounds. Of 
these, some of the compounds tentatively identified  
are chlorogenic acid, apiin, emodin 8-glucoside, 
petunidin, dihydromyricetin and swietenine (Fig. 6 & 
Table 6).  
 
Discussion  
The present study revealed the anti-hepatotoxic 
effect of the acetone extract of C. nucifera flowering 
inflorescence. Quantitative analysis revealed that  
C. nucifera inflorescence is rich in polyphenols  
(222.6 µg GAE/g dry extract) and flavonoids  
(120.8 µg QE/g dry extract). In DPPH assay, the 
phenolic rich CnAE reduces the DPPH radical to the 
corresponding hydrazine by releasing hydrogen ions. 
The highest percentage of DPPH radical scavenging 
activity of CnAE was found to be 72.50% at  
100 μg/mL. In ABTS assay, the blue green colour of 
ABTS radicals is reduced by the quenching effect of 
CnAE as similar to the DPPH assay31. CnAE at a  
dose of 100 μg/mL showed the highest percentage 
(69.96%) ABTS radical scavenging activity. The 
CnAE also showed significant ferric reducing power 
by donating hydrogen ions. The highest percentage of 
ferric reducing antioxidant capacity of CnAE was 
53.75% at 100 μg/mL. Ascorbic acid was used as the 
reference standard.  
The elevated level of intracellular enzymes like 
AST and ALT are the indication of oxidative 
membrane damage and instability in hepatocytes32.  
Table 3 — Effect of CnAE on liver function enzyme activities of experimental rats 
Experimental groups AST(IU/L) ALT(IU/L) ALP(IU/L) 
Group I (Normal control) 124.21±3.83 6.29±0.60 135.63±3.34 
Group II (APAP control) 203.64±9.19*** 22.09±2.43*** 218.55±11.58*** 
Group III (Silymarin 100 mg/kg) 138.06±7.84* 8.85±0.66ns 126.26±3.44ns 
Group IV (CnAE 100 mg/kg) 180.47±2.79*** 15.63±1.27*** 180.47±2.95** 
Group V (CnAE 200 mg/kg) 166.82±1.86*** 14.36±0.99*** 176.13±5.33** 
Group VI (CnAE 400 mg/kg) 149.08±4.01*** 10.19±1.24* 163.46±4.38* 
Values are mean ± SD, n=6; (∗∗∗) p<0.001, (∗∗) p<0.01 and (∗) p<0.05 compared with normal control. 
 
Table 4 — Effect of CnAE on liver antioxidant status of experimental rats 










Group I (Normal control) 53.46±5.23 6.73± 0.54 85.71±2.72 94.17±3.765 4.35±0.59 
Group II (APAP control) 10.51±0.76*** 1.71±0.36*** 41.75±2.99*** 44.13±2.83*** 13.40±0.84*** 
Group III (Silymarin 100 mg/kg) 44.04±4.47* 5.51±0.38** 78.13±2.56** 81.06±1.62*** 5.63±0.38ns 
Group IV (CnAE 100 mg/kg) 23.84±3.66*** 4.26±0.29*** 49.60±1.37*** 49.56±3.09*** 10.15±0.53*** 
Group V (CnAE 200 mg/kg) 30.19±1.47*** 4.98±0.17*** 56.04±2.50*** 65.16±2.88*** 8.75±0.62*** 
Group VI (CnAE 400 mg/kg) 35.22±1.25*** 5.25±0.17*** 74.39 ±1.92*** 76.76±1.51*** 6.35±0.50** 
Values are mean ± SD, n=6; (∗∗∗) p<0.001, (∗∗) p<0.01 and (∗) p<0.05 compared with normal control. 
 
Table 5 — Effect of CnAE on haematological parameters of experimental rats 
Experimental groups RBC (×106 /μL) WBC (×103/μL) Platelet (×103 /μL) 
Group I (Normal control) 8.23±0.85 13.94±1.18 1053.33±107.30 
Group II (APAP control) 16.50±1.62*** 32.90±2.56*** 247.83±40.85*** 
Group III (Silymarin100 mg/kg) 10.33±0.68** 19.22±0.70*** 634.67±50.24*** 
Group IV (CnAE 100 mg/kg) 14.99±0.84*** 30.38±3.51*** 288.67±37.43*** 
Group V (CnAE 200 mg/kg) 13.31±0.60*** 26.59±1.33*** 335.67±40.13*** 
Group VI (CnAE 400 mg/kg) 11.36±0.80*** 20.63±1.08*** 580.00±28.56*** 
Values are mean ± SD, n=6; (∗∗∗) p<0.001, (∗∗) p<0.01 and (∗) p<0.05 compared with normal control 
 




In the present study, pre-treatment with CnAE 
demonstrated a significant decline in serum 
concentrations of AST, ALT and ALP. All the 
concentrations of CnAE reduced the serum enzyme 
levels as compared to the levels in APAP-treated 
group, demonstrating dose dependent membrane 
stabilizing activity of CnAE. CnAE at higher 
concentration (400 mg/kg bw) exhibited greater 
reduction in AST, ALT and ALP levels (p<0.001) and 
is comparable with silymarin.  
Malondialdehyde is an indicator of tissue damage 
due to lipid peroxidation and is involving a series of 
chain reactions33,34. In our study, APAP alone 
administered group showed a drastic increase in MDA 
levels as compared to the normal group (p<0.001). 
However, pre-treatment with CnAE markedly 
prevented the increase in MDA formation. 
Reactive oxygen species induced oxidative stress 
combined with weakened cellular antioxidant system 
underlies the disruption of cellular homeostasis35. 
 
 
Fig. 5 — Photomicrographs of liver sections stained with H & E: (A) liver from a rat in normal control group pre-treated with distilled 
water; (B) liver from APAP-control group rat pre-treated with distilled water; (C) liver from a rat pre-treated with silymarin (100 mg/kg) 
followed by APAP treatment; (D) liver from a rat in the group pre-treated with CnAE (100 mg/kg) followed by APAP treatment; (E) liver 
from a rat in the group pre-treated with CnAE (200 mg/kg) followed by APAP treatment; (F) liver from a rat in the group pre-treated with 
CnAE (400 mg/kg) followed by APAP treatment. 
 




Several studies have shown that depletion of this 
intracellular antioxidant defence systems are the 
major mechanism in the development of APAP-
induced oxidative stress36,37. Our results showed that 
APAP-treatment significantly decreased the liver 
SOD, GSH, GPx and GST levels (p<0.001), which is 
in agreement with earlier reports38,39. However, it was 
noticed that the rats pre-treated with CnAE (200 and 
400 mg/kg b.w.) significantly raised the antioxidant 
status towards normal against the APAP-induced 
oxidative stress. These results suggested that CnAE 
might have a liver protective effect by decreasing 
APAP-induced oxidative stress.  
It is found that the histopathological results are in 
good concurrence with biochemical estimations.  
The normal control group showed cells with a well 
preserved cytoplasm, normal lobular architecture and 
well defined nucleus. The higher concentration of 
CnAE (400 mg/kg bw) showed more prominent signs 
of recovery than the other concentrations tested. 
Earlier reports on similar studies showed a marked 
and widespread inflammation and infiltration in the 
APAP-control group40,41. The silymarin treated group 
also significantly reversed APAP-induced liver injury. 
In line with diagnostic significance, haematological 
parameters namely RBC, WBC and platelet counts 
were also monitored. It was found that APAP-
treatment significantly increased the RBC and WBC 
counts and reduced the platelet count. Pre-treatment 
with CnAE significantly ameliorated the APAP-
induced effect. 
Several studies have shown antioxidant and 
hepatoprotective activities of different classes of 
polyphenols38,42. Polyphenols interact with the cells 
mainly through receptors or enzymes involved in signal 
transduction43-45. Interestingly, compounds tentatively 
identified by LC-MS analysis are phenolic/flavonoid 
class of compounds. A thorough literature search 
revealed that all these identified compounds 
Table 6 — Compounds tentatively identified from HR LC-MS analysis of CnAE 
Sl No. Compound name Retention time Molar mass Molecular formula Molecular structure  
1 Chlorogenic acid 5.392 354.0916 C16H18O9 
 
2 Apiin 5.959 564.1426 C26H28O14 
 
3 Emodin 8-glucoside 6.509 432.1017 C21H20O10 
 
4 Petunidin 6.537 317.0631 C16 H13O7  
 





Fig. 6 — HR LC-MS chromatogram of CnAE 
 




(chlorogenic acid, apiin, emodin 8-glucoside, petunidin 
and dihydromyricetin) showed significant antioxidant 
and hepatoprotective activities46-52. This might be a 
reason for the antioxidant and hepatoprotective effect 
of CnAE. Collectively, our data strongly exposed the 
clinical potential of the polyphenol-enriched fraction 
from C. nucifera inflorescence as a nutraceutical/ 
functional food ingredient for the prevention of toxin-
induced hepatic injury. 
 
Conclusion 
In conclusion, our findings clearly demonstrated 
the hepatoprotective effect of phenolic-rich acetone 
extract of Cocos nucifera inflorescence. The detailed 
chemical and pharmacological investigations can be 
helpful in finding the desired bioactive molecules and 
their mechanism of action. 
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